Login / Signup
Adjuvant alectinib improves outcomes in ALK-mutant NSCLC.
Diana Romero
Published in:
Nature reviews. Clinical oncology (2024)
Keyphrases
</>
advanced non small cell lung cancer
small cell lung cancer
early stage
epidermal growth factor receptor
wild type
type diabetes
metabolic syndrome
adipose tissue
insulin resistance
tyrosine kinase